Home

Inactivo Abolladura resultado ipo abcellera soporte interior Ahora

AbCellera Announces Pricing of Initial Public Offering | Business Wire
AbCellera Announces Pricing of Initial Public Offering | Business Wire

IPO Alert: AbCellera Biologics (ABCL)
IPO Alert: AbCellera Biologics (ABCL)

VC-backed AbCellera seeks up to C$500m from IPO: Reuters
VC-backed AbCellera seeks up to C$500m from IPO: Reuters

Peter Thiel Is Said to Get Board Seat at AbCellera as IPO Nears - BNN  Bloomberg
Peter Thiel Is Said to Get Board Seat at AbCellera as IPO Nears - BNN Bloomberg

IPO: AbCellera Biologics
IPO: AbCellera Biologics

DoorDash, Airbnb Lead Big IPO Week—but Peter Thiel's AbCellera Could Be the  Winner | Barron's
DoorDash, Airbnb Lead Big IPO Week—but Peter Thiel's AbCellera Could Be the Winner | Barron's

AbCellera officially closes initial public offering with $555.5 million  gross proceeds | BetaKit
AbCellera officially closes initial public offering with $555.5 million gross proceeds | BetaKit

AbCellera Biologics to raise up to US $391M from NASDAQ IPO at up to US  $4.52B valuation - Private Capital Journal
AbCellera Biologics to raise up to US $391M from NASDAQ IPO at up to US $4.52B valuation - Private Capital Journal

IPO Launch: AbCellera Biologics Readies $357 Million IPO - IPOs On  TheStreet - U.S. IPO Research & Opinion
IPO Launch: AbCellera Biologics Readies $357 Million IPO - IPOs On TheStreet - U.S. IPO Research & Opinion

AI drug discovery platform AbCellera prices upsized IPO at $20, above the  upwardly revised range - Renaissance Capital
AI drug discovery platform AbCellera prices upsized IPO at $20, above the upwardly revised range - Renaissance Capital

Abcellera Biologics Inc. | BioWorld
Abcellera Biologics Inc. | BioWorld

AbCellera: Why I Don't Love This Drug Discoverer's Business Model  (NASDAQ:ABCL) | Seeking Alpha
AbCellera: Why I Don't Love This Drug Discoverer's Business Model (NASDAQ:ABCL) | Seeking Alpha

AbCellera IPO: Stock to Fund COVID Antibody Therapy
AbCellera IPO: Stock to Fund COVID Antibody Therapy

Thiel-backed therapy developer AbCellera looks to raise up to $391 million  in IPO | Reuters
Thiel-backed therapy developer AbCellera looks to raise up to $391 million in IPO | Reuters

Wish & AbCellera Biologics Inc: Investors' Hawk-eyed On These 2 IPOs |  Kalkine Media
Wish & AbCellera Biologics Inc: Investors' Hawk-eyed On These 2 IPOs | Kalkine Media

AbCellera Biologics's billionaire boss planning hiring spree in Vancouver  hometown after record-setting IPO - : r/canada
AbCellera Biologics's billionaire boss planning hiring spree in Vancouver hometown after record-setting IPO - : r/canada

IPO Stock AbCellera Eyes Profitability As Covid-19 Antibody Sales Soar |  Investor's Business Daily
IPO Stock AbCellera Eyes Profitability As Covid-19 Antibody Sales Soar | Investor's Business Daily

Vancouver-based AbCellera Goes Public on Nasdaq with Massive US $555.5M IPO,  Company's Market Value Triples to $15.7 Billion on 1st Day | T-Net News
Vancouver-based AbCellera Goes Public on Nasdaq with Massive US $555.5M IPO, Company's Market Value Triples to $15.7 Billion on 1st Day | T-Net News

COVID-19 Antibody Discovery Company Preps for Massive $391 Million IPO |  BioSpace
COVID-19 Antibody Discovery Company Preps for Massive $391 Million IPO | BioSpace